POP SILICA

Towards Biodegradable Nanoparticles: Hybrid Organic Mesoporous Silica

Coordinatore	UNIVERSITE DE STRASBOURG    more  Organization address address: rue Blaise Pascal 4 city: Strasbourg postcode: 67070 contact info Titolo: Mrs. Nome: Sandrine Cognome: Schott-Carrière Email: send email Telefono: +33 368851124
Nazionalità Coordinatore	France [FR]
Totale costo	97˙023 €
EC contributo	97˙023 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2013-IEF
Funding Scheme	MC-IEF
Anno di inizio	2014
Periodo (anno-mese-giorno)	2014-03-01   -   2015-02-28

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	UNIVERSITE DE STRASBOURG  Organization address address: rue Blaise Pascal 4 city: Strasbourg postcode: 67070 contact info Titolo: Mrs. Nome: Sandrine Cognome: Schott-Carrière Email: send email Telefono: +33 368851124	FR (Strasbourg)	coordinator	97˙023.30

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Despite their great potential, full exploitation of mesoporous silica nanoparticles (MSiNPs) as in-vivo multi-functional theranostic agents is still held back by the lack of a controlled and complete biodegradability. Indeed removal of nano-medical tools from the biologic system after the accomplishment of their diagnostic or therapeutic function still remains a pivotal, yet unresolved issue impeding their clinical translation. A most desirable design for improving the properties of nano-medical tools would hence involve their ability to hierarchically self-degrade into renally clearable products after carrying out their function. Thus, the ambitious aim of this project targets the synthesis of novel, specific, hybrid MSiNPs-based theranostic tools, able to perform their beneficial action and subsequently fragment in smaller pieces allowing easy execration via renal system. In this way, thanks to the combination of the intrinsic biocompatibility of MSiNPs, their ease of functionalization and the newly conferred enhanced biodegradability, a superior material adaptable to a wide range of diagnostic and therapeutic applications, with great promise for clinical translation, will be achieved.'